While many advocate that oversight of AI analyses of lab data be handled through CLIA, some stakeholders say that FDA should play a role.
After two decades effecting change in commercial diagnostics, this achievement is the brightest spot of my career, with a profound culmination of scientific, clinical, and social impact," —Elizabeth ...
FOSTER CITY, Calif., May 28, 2025 /PRNewswire/ -- 1Cell.Ai, a precision oncology company developing advanced cell and molecular profiling platforms, announced the successful completion of a CLIA-grade ...
The successful translation of biomarker discoveries into actionable diagnostic tools requires strict adherence to the robust regulations governing clinical proteomics. As mass spectrometry and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results